CTRI/2018/02/011819尚未招募4 期
An open label clinical study to evaluate the safety and efficacy of Isha Balm an ayurvedic proprietary topical application for mild to moderate headache and nasal symptoms
Isha Arogya pvt ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1Patients attending the clinic in the age group of 12 years and above and both the sexes included
- •2 Patients provisionally diagnosed to have viral prodrome, common cold, acute sinusitis, tension headache, migraine headache with the symptom of headache are included the study with their consent.
排除标准
- •1 past medical records needing neurological evaluation for headache
- •2known cases of hypertention, and those getting treatment complications of uncontrolled hypertention
- •3having ophthalmic complaints
- •4Patients with serious co-morbid illnesses such as known cardiac vascular disease, cancer induced pain, injuries due to fall or accidents, systemic illness like SLE,etc
- •Patients below the age of 12 years and above 60 years.
- •Patients who are not willing to give informed written consent.
研究者
相似试验
已完成
不适用
A clinical study to evaluate the glycemic index (glucose level in blood in 2 Hour period) and safety of COCOZEN in Human Volunteers.CTRI/2018/03/012389Akay Flavours and Aromatics Private Limited20
已完成
不适用
CelWel in Long CovidCTRI/2022/12/048144Carmel Research Consultancy Private Limited15
已完成
不适用
Clinical Study For Patients Requiring Tube FeedingCTRI/2019/12/022446Modi Mundi Pharma Private Limited15
已完成
不适用
Clinical Study For Hospitalized Patients Requiring isocaloric formulafor enteral tube feedingCTRI/2020/09/027831Modi Mundi Pharma Private Limited15
进行中（未招募）
1 期
An open-label clinical study to evaluate the safety and antiepileptic activity of ganaxolaone in treatment of patients diagnosed with infantile spansms.EUCTR2006-004286-33-PLMarinus Pharmceuticals, Inc.54